Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathwaySushil Kumar, Rumela Chakrabarti|Nature Communications|2021Cited by 80
IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activitySushil Kumar, Himanshu Kumar|Cell Death and Disease|2015Cited by 48